Is Internet Addiction Prevalent Among Methadone Maintenance Treatment Patients? Data from Las Vegas and Tel Aviv.Drug addiction and stress-response genetic variability: association study in African Americans.Can a 12-step program work in methadone maintenance treatment?Haplotype block structure of the genomic region of the mu opioid receptor gene.Dopaminergic pathway polymorphisms and heroin addiction: further support for association of CSNK1E variants.Overlapping dopaminergic pathway genetic susceptibility to heroin and cocaine addictions in African Americans.Glutamatergic and GABAergic susceptibility loci for heroin and cocaine addiction in subjects of African and European ancestrySynaptic Plasticity and Signal Transduction Gene Polymorphisms and Vulnerability to Drug Addictions in Populations of European or African Ancestry.Estimating ancestral proportions in a multi-ethnic US sample: implications for studies of admixed populations.Drug addiction from a psychodynamic perspective: methadone maintenance treatment (MMT) as transitional phenomena.Susceptibility loci for heroin and cocaine addiction in the serotonergic and adrenergic pathways in populations of different ancestryABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence.CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction.African-specific variability in the acetylcholine muscarinic receptor M4: association with cocaine and heroin addiction.One-year and cumulative retention as predictors of success in methadone maintenance treatment: a comparison of two clinics in the United States and Israel.Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction.Cognitive function is largely intact in methadone maintenance treatment patients.Sexual Abuse and its Relation to Chronic Pain among Women from a Methadone Maintenance Clinic versus a Sexual Abuse Treatment Center.Differences in methylphenidate abuse rates among methadone maintenance treatment patients in two clinics.Psychiatric comorbidity differences between women with history of childhood sexual abuse who are methadone-maintained former opiate addicts and non-addicts.The differential effect of methadone dose and of chronic pain on pain perception of former heroin addicts receiving methadone maintenance treatment.Risk factors for weight gain during methadone maintenance treatment.Ten Years of Abstinence in Former Opiate Addicts: Medication-Free Non-Patients Compared to Methadone Maintenance Patients.Benzodiazepine usage during 19.5 years in methadone maintenance treatment patients and its relation to long-term outcome.The Prevalence of Alcohol, Substance and Cigarettes Exposure among Pregnant Women within a General Hospital and the Compliance to Brief Intervention for Exposure Reduction.Trends in substance abuse and infectious disease over 20 years in a large methadone maintenance treatment (MMT) clinic in Israel.Treatment of benzodiazepine dependence in methadone maintenance treatment patients: a comparison of two therapeutic modalities and the role of psychiatric comorbidity.Cannabis abuse is not a risk factor for treatment outcome in methadone maintenance treatment: a 1-year prospective study in an Israeli clinic.Characterization of former heroin addict patients with Hepatitis C virus antibodies in a methadone maintenance treatment (MMT) clinic in israel.Sense of coherence as a stable predictor for methadone maintenance treatment (MMT) outcome.15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel.Stroop task among patients with obsessive-compulsive disorder (OCD) and pathological gambling (PG) in methadone maintenance treatment (MMT).Impact of lifetime psychiatric diagnosis on long-term retention and survival of former opiate addicts in methadone maintenance treatment.Benzodiazepine abuse in a methadone maintenance treatment clinic in Israel: characteristics and a pharmacotherapeutic approach.Is a History of Sexual Abuse Related to Poor Sleep Among Former Opioid-Addicted Women With and Without Methadone Maintenance Treatment?The μ-opioid receptor nonsynonymous variant 118A>G is associated with prolonged abstinence from heroin without agonist treatment.Association of OCD with a history of traumatic events among patients in methadone maintenance treatment.Documented poor sleep among methadone-maintained patients is associated with chronic pain and benzodiazepine abuse, but not with methadone dose.Variables associated with perceived sleep disorders in methadone maintenance treatment (MMT) patients.Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel.
P50
Q30987898-658EE2CF-FFEB-4F36-8E54-DC767151A389Q33784764-9B6BFCC3-960A-48A9-9F16-E305383A544DQ34141765-BE40B62C-C375-4CF6-B3CD-EB414F1E3DC3Q34786964-C92CD03E-A507-4849-847D-DE8D4836B8CEQ34891066-D8A1F15D-9124-4BDA-9D19-23F898C6B2CAQ35439069-A3A170A8-B2C0-42D2-ADE1-91530686012AQ36042323-493AB10B-C479-4D77-B642-1EE6DD59A083Q36202656-BB31FEDD-B324-4F1A-93BC-247DDAD82C13Q36220583-93123D0E-3301-487B-86BE-49D3DE517B47Q36834476-0E093BCB-951D-4268-A47C-90923ECCDDFBQ36976562-E45A45EF-535C-4527-B7BE-BAABE3E0AD7BQ37008505-75DB1082-4A33-4F2B-834E-1397B5F6EC72Q37075089-F506B2D1-2DBB-4D15-B45C-148116E3DF4EQ37200655-A0FCD3C7-E07B-447D-8322-189933CA7CD0Q37260362-47008F96-8253-4B46-A814-0EB74F9DFA5CQ37401604-9036B4A8-1867-4B73-B566-64D4E57AD2B1Q38375656-140BF584-5DB0-4DC7-B7CE-466C40D4CF8FQ38840444-12060AE8-3164-4B89-8422-610DF0EBE42AQ39052538-181A7B08-6F92-4E88-AD91-DBF80919ACB7Q39178978-C1CD6203-9417-4E44-86AF-B917F3E823BFQ39862216-FFF16207-8D90-41C6-990A-F064DD6241B7Q40534203-CF842C1D-D180-4405-A335-CBDB0665B432Q40630930-1C8142ED-FA54-425F-B67B-CCD8D0F73CEFQ41116819-5651D8EE-8255-4AE3-A995-7C7F1730017EQ41116838-5C93D082-54AE-45DB-A213-F7416EB521D0Q42220594-4CB09F12-78A9-437A-91B3-B09F70C1488EQ42604009-C35B0B94-8AA3-468D-8E51-97C5BE9113BCQ42617605-3E41B99D-3C3F-41F6-A1DF-506640BAA663Q43040901-82D80AF8-1084-4ABC-94E1-8D3296CD21B3Q43226440-69A17ADB-8E74-4386-9128-DC464EC177CCQ43241999-D173E1A1-70DC-4D75-A68F-EC22A047F8AEQ43871084-252AF6E6-6E35-4939-B285-A5D9B2E3D21CQ44121877-D89772DC-ED47-4982-A0F4-7F057AF46994Q44134412-0EC15726-E9EE-4193-9825-928B2379FF0CQ44345369-52F1BA07-5A6C-4A5A-9DCD-CD896F4270F7Q44349482-059B4BAA-4A24-4196-8BC7-799807F86EA5Q45271707-A8221E0C-3D84-4096-B5EB-8B3512239F9EQ46027619-3496A468-957A-4CD4-B844-2AE2A56F27F4Q46696112-3D87D983-C55D-451D-A966-017C8B85D4B6Q46747753-6786F77C-0E8C-42FC-8B1C-550B70C10224
P50
description
Amerikaans filantropino
@nl
Israeli American philanthropist, doctor and political donor
@en
izraelsko-americká lékařka a filantropka
@cs
philanthrope israélo-américaine
@fr
רופאה ופילנטרופית ישראלית-אמריקאית
@he
name
Miriam Adelson
@ast
Miriam Adelson
@ca
Miriam Adelson
@en
Miriam Adelson
@es
Miriam Adelson
@fr
Miriam Adelson
@nl
Miriam Adelson
@sl
Miriam Adelsonová
@cs
Мириам Адельсон
@ru
מרים אדלסון
@he
type
label
Miriam Adelson
@ast
Miriam Adelson
@ca
Miriam Adelson
@en
Miriam Adelson
@es
Miriam Adelson
@fr
Miriam Adelson
@nl
Miriam Adelson
@sl
Miriam Adelsonová
@cs
Мириам Адельсон
@ru
מרים אדלסון
@he
altLabel
Miriam Farbstein
@en
Miriam Ochshorn
@en
מרים אוקסהורן
@he
מרים פרבשטין
@he
prefLabel
Miriam Adelson
@ast
Miriam Adelson
@ca
Miriam Adelson
@en
Miriam Adelson
@es
Miriam Adelson
@fr
Miriam Adelson
@nl
Miriam Adelson
@sl
Miriam Adelsonová
@cs
Мириам Адельсон
@ru
מרים אדלסון
@he
P69
P19
P21
P31
P373
Miriam Adelson
P569
1945-10-10T00:00:00Z